Indication
Ampullary Cancer
3 clinical trials
5 products
1 drug
Product
CTX-009Clinical trial
A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination With Paclitaxel Versus Paclitaxel Alone in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers Who Have Received One Prior Systemic Chemotherapy RegimenStatus: Recruiting, Estimated PCD: 2025-07-01
Product
PaclitaxelClinical trial
Evaluation of the Role of Proton Pump Inhibitors on the Postoperative Course Following PancreaticoduodenectomyStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Product
PlaceboProduct
PantoprazoleClinical trial
A Phase Ib, Multi-centre, Open-label Study of a First-in-class Nucleotide Analogue Acelarin (NUC-1031) in Combination With Cisplatin in Patients With Locally Advanced/Metastatic Biliary Tract CancersStatus: Completed, Estimated PCD: 2019-03-01
Product
AcelarinDrug
Cisplatin